News
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $44.33, a high estimate of $58.00, and a low estimate of $37.00. This upward trend is evident, ...
Circle stock downgraded to Sell by Wall Street analyst citing rising competition, valuation concerns
Circle ( CRCL) stock fell as much as 8% Tuesday after getting hit with a downgrade from Compass Point analysts who said the ...
Centene Corp. (NYSE:CNC) is one of the most oversold S&P 500 stocks so far in 2025. On July 2, Centene’s share price plunged ...
On Monday, a frenzy of activity in shares of Opendoor Technologies Inc. saw more than 1.8 billion shares of the iBuyer change hands. That was roughly three times the company's public float. Opendoor ...
Magnera Corporation (NYSE: MAGN) today announced they will attend the 2025 Mizuho Industrials & Chemicals Conference in New York, NY. Magnera CFO, Jim Till, and EVP, Corporate Development, Investor ...
There is a new player making waves in an industry dominated by big banks. Imprint is a five year old startup taking on ...
SoftBank and OpenAI’s partnership on a $500 billion project to build AI data centers stalls six months after launch.
MainStreet Bancshares Inc (MNSB) is expected to report $0.42 for 2Q. Mercantile Bank Corp (MBWM) is expected to report $1.24 for 2Q. Mueller Industries Inc (MLI) is expected to report $1.61 for 2Q.
President Eiichi Yamazaki said that Mizuho Investor Relations will leverage its extensive data on institutional investors' ...
The Social Democratic Party (SDP) secured 2% of votes in the July 20 House of Councillors proportional representation bloc, ...
In accordance with Article 5 (1) (b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), ...
23h
Fintel on MSNMizuho Downgrades Sarepta Therapeutics (SRPT)Fintel reports that on July 21, 2025, Mizuho downgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from Outperform to Neutral. Analyst Price Forecast Suggests 274.14% Upside As of July 17, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results